These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 16250860)

  • 1. Homocysteine-lowering treatment in coronary heart disease.
    Cesari M; Rossi GP; Pessina AC
    Curr Med Chem Cardiovasc Hematol Agents; 2005 Oct; 3(4):289-95. PubMed ID: 16250860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is homocysteine important as risk factor for coronary heart disease?
    Cesari M; Rossi GP; Sticchi D; Pessina AC
    Nutr Metab Cardiovasc Dis; 2005 Apr; 15(2):140-7. PubMed ID: 15871863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin supplementation normalizes total plasma homocysteine concentration but not plasma homocysteine redox status in patients with acute coronary syndromes and hyperhomocysteinemia.
    Andersson A; Jonasson T; Ohlin H; Lindgren A; Hultberg B
    Clin Chem Lab Med; 2002 Jun; 40(6):554-8. PubMed ID: 12211647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective study of coronary heart disease incidence in relation to fasting total homocysteine, related genetic polymorphisms, and B vitamins: the Atherosclerosis Risk in Communities (ARIC) study.
    Folsom AR; Nieto FJ; McGovern PG; Tsai MY; Malinow MR; Eckfeldt JH; Hess DL; Davis CE
    Circulation; 1998 Jul; 98(3):204-10. PubMed ID: 9697819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma homocysteine and markers for oxidative stress and inflammation in patients with coronary artery disease--a prospective randomized study of vitamin supplementation.
    Jonasson T; Ohlin AK; Gottsäter A; Hultberg B; Ohlin H
    Clin Chem Lab Med; 2005; 43(6):628-34. PubMed ID: 16006259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Homocysteine and C-reactive protein levels in haemodialysis patients.
    Koulouridis E; Tzilianos M; Katsarou A; Costimba I; Klonou E; Panagiotaki E; Georgalidis C; Krokida A; Delaportas N; Lachanas A; Karaliotas G; Kaliolia I
    Int Urol Nephrol; 2001; 33(2):207-15. PubMed ID: 12092633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homocysteine-lowering is not a primary target for cardiovascular disease prevention in chronic kidney disease patients.
    Suliman ME; Lindholm B; Bárány P; Qureshi AR; Stenvinkel P
    Semin Dial; 2007; 20(6):523-9. PubMed ID: 17991198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preventive health care, 2000 update: screening and management of hyperhomocysteinemia for the prevention of coronary artery disease events. The Canadian Task Force on Preventive Health Care.
    Booth GL; Wang EE
    CMAJ; 2000 Jul; 163(1):21-9. PubMed ID: 10920726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of vitamin therapy to lower plasma homocysteine levels for the prevention of coronary heart disease: effect of grain fortification and beyond.
    Tice JA; Ross E; Coxson PG; Rosenberg I; Weinstein MC; Hunink MG; Goldman PA; Williams L; Goldman L
    JAMA; 2001 Aug 22-29; 286(8):936-43. PubMed ID: 11509058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved vascular endothelial function after oral B vitamins: An effect mediated through reduced concentrations of free plasma homocysteine.
    Chambers JC; Ueland PM; Obeid OA; Wrigley J; Refsum H; Kooner JS
    Circulation; 2000 Nov; 102(20):2479-83. PubMed ID: 11076820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes.
    Boushey CJ; Beresford SA; Omenn GS; Motulsky AG
    JAMA; 1995 Oct; 274(13):1049-57. PubMed ID: 7563456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Homocysteine-lowering vitamins do not lower plasma S-adenosylhomocysteine in older people with elevated homocysteine concentrations.
    Green TJ; Skeaff CM; McMahon JA; Venn BJ; Williams SM; Devlin AM; Innis SM
    Br J Nutr; 2010 Jun; 103(11):1629-34. PubMed ID: 20089204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Homocysteine, vitamins, and coronary artery disease. Comprehensive review of the literature.
    Taylor BV; Oudit GY; Evans M
    Can Fam Physician; 2000 Nov; 46():2236-45. PubMed ID: 11143583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Homocysteine lowering effect of different multivitamin preparations in patients with end-stage renal disease.
    Dierkes J; Domröse U; Bosselmann KP; Neumann KH; Luley C
    J Ren Nutr; 2001 Apr; 11(2):67-72. PubMed ID: 11295026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of folic acid supplementation on plasma total homocysteine are modulated by multivitamin use and methylenetetrahydrofolate reductase genotypes.
    Malinow MR; Nieto FJ; Kruger WD; Duell PB; Hess DL; Gluckman RA; Block PC; Holzgang CR; Anderson PH; Seltzer D; Upson B; Lin QR
    Arterioscler Thromb Vasc Biol; 1997 Jun; 17(6):1157-62. PubMed ID: 9194768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Creatine supplementation does not decrease total plasma homocysteine in chronic hemodialysis patients.
    Taes YE; Delanghe JR; De Bacquer D; Langlois M; Stevens L; Geerolf I; Lameire NH; De Vriese AS
    Kidney Int; 2004 Dec; 66(6):2422-8. PubMed ID: 15569335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B-Vitamin Therapy for Kidney Transplant Recipients Lowers Homocysteine and Improves Selective Cognitive Outcomes in the Randomized FAVORIT Ancillary Cognitive Trial.
    Scott TM; Rogers G; Weiner DE; Livingston K; Selhub J; Jacques PF; Rosenberg IH; Troen AM
    J Prev Alzheimers Dis; 2017; 4(3):174-182. PubMed ID: 29182708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum homocysteine and folate but not vitamin B12 are predictors of CHD mortality in older adults.
    Gopinath B; Flood VM; Rochtchina E; Thiagalingam A; Mitchell P
    Eur J Prev Cardiol; 2012 Dec; 19(6):1420-9. PubMed ID: 21960652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Homocysteine-lowering vitamin B treatment decreases cardiovascular events in hemodialysis patients.
    Righetti M; Serbelloni P; Milani S; Ferrario G
    Blood Purif; 2006; 24(4):379-86. PubMed ID: 16755160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DACH-LIGA homocystein (german, austrian and swiss homocysteine society): consensus paper on the rational clinical use of homocysteine, folic acid and B-vitamins in cardiovascular and thrombotic diseases: guidelines and recommendations.
    Stanger O; Herrmann W; Pietrzik K; Fowler B; Geisel J; Dierkes J; Weger M;
    Clin Chem Lab Med; 2003 Nov; 41(11):1392-403. PubMed ID: 14656016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.